EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients

Xihong Zhang, Chungen Qian, Li Yang, Huixia Gao, Ping Jiang, Muwei Dai, Yuling Wang, Haiyan Kang, Yi Xu, Qian Hu, Fumin Feng, Bangning Cheng und 1 weitere

PeerJ · 2023

DOI: 10.7717/peerj.15515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Xihong Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, North China University of Science and Technology, Tangshan, Hebei, China. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Hebei province, Research and Development Program of Shijiazhuang Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid antigen (N-Ag) remains to be fully elucidated. In this study, we sought to investigate the value of serum SARS-CoV-2 N-Ag for COVID-19 diagnosis and to analyze N-Ag characteristics in COVID-19 individuals.

Methods

Serum samples collected from 215 COVID-19 patients and 65 non-COVID-19 individuals were used to quantitatively detect N-Ag via chemiluminescent immunoassay according to the manufacturer’s instructions.

Results

The sensitivity and specificity of the N-Ag assay were 64.75% (95% confidence interval (95% CI) [55.94–72.66%]) and 100% (95% CI [93.05–100.00%]), respectively, according to the cut-off value recommended by the manufacturer. The receiver operating characteristic (ROC) curve showed a sensitivity of 100.00% (95% CI [94.42–100.00%]) and a specificity of 71.31% (95% CI [62.73–78.59%]). The positive rates and levels of serum SARS-CoV-2 N-Ag were not related to sex, comorbidity status or disease severity of COVID-19 (all P < 0.001). Compared with RT‒PCR, there was a lower positive rate of serum N-Ag for acute COVID-19 patients ( P < 0.001). The positive rate and levels of serum SARS-CoV-2 N-Ag in acute patients were significantly higher than those in convalescent patients (all P < 0.001). In addition, the positive rate of serum SARS-CoV-2 N-Ag in acute COVID-19 patients was higher than that of serum antibodies (IgM, IgG, IgA and neutralizing antibodies (Nab)) against SARS-CoV-2 (all P < 0.001). However, the positive rate of serum SARS-CoV-2 N-Ag in convalescent COVID-19 patients was significantly lower than that of antibodies (all P < 0.001).

Conclusion

Serum N-Ag can be used as a biomarker for early COVID-19 diagnosis based on appropriate cut-off values. In addition, our study also demonstrated the relationship between serum N-Ag and clinical characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansCOVID-19 TestingSARS-CoV-2NucleocapsidAntibodies, Neutralizing

Stichwörter der Autor:innen

COVID-19DiagnosisNucleocapsid antigenSARS-CoV-2Serum

Substanzen

Antibodies, Neutralizing

Autor:innen und Institutionen

  • School of Public Health, North China University of Science and Technology, Tangshan, Hebei, China.
  • Department of Laboratory Medicine, The Fifth Hospital of Shijiazhuang, North China University of Science and Technology, Shijiazhuang, Hebei, China.
  • The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, C…
  • Department of Tuberculosis, The Fifth Hospital of Shijiazhuang, North China University of Science and Technology, Shijiazhuang, Hebei, China.
  • Orthopaedic Department, The Fourth Hospital of Hebei Medical University and Hebei Cancer Hospital, Shijiazhuang, Hebei, China.
  • Shenzhen YHLO Biotech Co., Ltd, Shenzhen, Guangdong, China.

Förderung

  • Key Research and Development Program of Hebei province
  • Research and Development Program of Shijiazhuang Science and Technology

Zitieren

APA

Zhang, X., Qian, C., Yang, L., Gao, H., Jiang, P., Dai, M., Wang, Y., Kang, H., Xu, Y., Hu, Q., Feng, F., Cheng, B., & Dai, E. (2023). Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients. PeerJ. https://doi.org/10.7717/peerj.15515

Vancouver

Zhang X, Qian C, Yang L, Gao H, Jiang P, Dai M, et al. Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients. PeerJ. 2023. doi:10.7717/peerj.15515

BibTeX
@article{Zhang2023,
  author = {Zhang, Xihong and Qian, Chungen and Yang, Li and Gao, Huixia and Jiang, Ping and Dai, Muwei and Wang, Yuling and Kang, Haiyan and Xu, Yi and Hu, Qian and Feng, Fumin and Cheng, Bangning and Dai, Erhei},
  title = {Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.15515}
}
Kostenlos starten →